VolitionRx Limited - התחייבויות לטווח ארוך של החברה VNRX

Market price action on GURU.Markets helps assess the debt load of VolitionRx Limited (VNRX), which currently stands at 0.00. VolitionRx Limited (VNRX) develops innovative AI tests for early oncology diagnostics, leveraging unique patents for nucleosome analysis. Demand for such services remains independent of economic downturns, as it relies on medical protocols. High utilization of modernized production capacities confirms the active commercial development of the business.

This indicator aggregates obligations with maturities exceeding twelve months, reflecting the long-term credit load on the issuer's balance sheet. Assessing the organization's long-term financial debt determines the stability of VolitionRx Limited (VNRX) while scaling Nu.Q AI diagnostics and protecting its patent portfolio, helping investors balance leverage risks against the growth potential of the biopharmaceutical business.